Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia

Bruce D. Cheson, John C. Byrd, Kanti R. Rai, Neil E. Kay, Susan M. O'Brien, Ian W. Flinn, Adrian Wiestner, Thomas J. Kipps

Research output: Contribution to journal › Comment/debate › peer-review

152 Scopus citations

Fingerprint

Dive into the research topics of 'Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia'. Together they form a unique fingerprint.